Skip to main content

SUMO Activating Enzyme E1 (SAE1/UBA2): Antibodies

Small Ubiquitin-like Modifier (SUMO) Activating Enzyme Subunit 1 (SAE1) is the highly conserved human ortholog of yeast Ubiquitin-activating enzyme E1-like (UBA2). These SUMO-activating (E1) enzymes are critical for the enzymatic attachment of SUMO molecules to a target protein by a post-translational modification process termed SUMOylation. The ATP-dependent E1 enzyme charges the SUMO by forming a high-energy thiol ester intermediate which is transferred to the UBE2I/Ubc9 SUMO-conjugating (E2) enzyme. The second step is the trans-esterification reaction whereby SUMO is transferred to Cys93 of UbcH9. UBE2I/Ubc9 is the only known E2 that is able to mediate the conjugation of SUMO to lysine residues on a variety of cellular targets, usually in the absence of a Ubiquitin ligase (E3). Although UBE2I/Ubc9 can directly recognize and modify lysine residues contained in a SUMOylation motif, E3-like factors most likely facilitate the SUMOylation of specific substrates.

Show More

36 results for "SUMO Activating Enzyme E1 (SAE1/UBA2) Primary Antibodies" in Products

36 results for "SUMO Activating Enzyme E1 (SAE1/UBA2) Primary Antibodies" in Products

SUMO Activating Enzyme E1 (SAE1/UBA2): Antibodies

Small Ubiquitin-like Modifier (SUMO) Activating Enzyme Subunit 1 (SAE1) is the highly conserved human ortholog of yeast Ubiquitin-activating enzyme E1-like (UBA2). These SUMO-activating (E1) enzymes are critical for the enzymatic attachment of SUMO molecules to a target protein by a post-translational modification process termed SUMOylation. The ATP-dependent E1 enzyme charges the SUMO by forming a high-energy thiol ester intermediate which is transferred to the UBE2I/Ubc9 SUMO-conjugating (E2) enzyme. The second step is the trans-esterification reaction whereby SUMO is transferred to Cys93 of UbcH9. UBE2I/Ubc9 is the only known E2 that is able to mediate the conjugation of SUMO to lysine residues on a variety of cellular targets, usually in the absence of a Ubiquitin ligase (E3). Although UBE2I/Ubc9 can directly recognize and modify lysine residues contained in a SUMOylation motif, E3-like factors most likely facilitate the SUMOylation of specific substrates.

Show More
Applications: IHC, WB
Reactivity: Human, Mouse, Rat
Applications: IHC, WB
Reactivity: Human, Mouse, Rat
Applications: IHC, WB, ELISA, ICC/IF
Reactivity: Human
Applications: IHC, WB
Reactivity: Human, Mouse, Rat
Applications: WB, ELISA, ICC/IF
Reactivity: Human

Recombinant monoclonal antibody expressed in HEK293F cells

Applications: WB
Reactivity: Human, Mouse, Rat

Recombinant Monoclonal Antibody

Applications: WB, ELISA
Reactivity: Human
Applications: WB, ELISA
Reactivity: Human
Applications: WB, ELISA
Reactivity: Human
Applications: WB
Reactivity: Human
Applications: IHC, WB
Reactivity: Human, Mouse, Rat
Applications: IHC, WB
Reactivity: Human, Mouse, Rat
Applications: IHC, WB
Reactivity: Human, Mouse, Rat
Applications: IHC, WB
Reactivity: Human, Mouse, Rat
Applications: IHC, WB
Reactivity: Human, Mouse, Rat
Applications: IHC, WB
Reactivity: Human, Mouse, Rat
Applications: IHC, WB
Reactivity: Human, Mouse, Rat
Applications: IHC, WB
Reactivity: Human, Mouse, Rat
Applications: IHC, WB
Reactivity: Human, Mouse, Rat
Applications: IHC, WB
Reactivity: Human, Mouse, Rat
Applications: IHC, WB
Reactivity: Human, Mouse, Rat
Applications: IHC, WB
Reactivity: Human, Mouse, Rat
Applications: IHC, WB
Reactivity: Human, Mouse, Rat
Applications: IHC, WB
Reactivity: Human, Mouse, Rat
Applications: IHC, WB
Reactivity: Human, Mouse, Rat
Results Per Page
5 10 25 50
/ 2